Archive
The Peptide Boom: Separate Oral Evidence From Topical Claims
The randomized evidence is encouraging but route-, formula- and endpoint-specific; oral collagen-derived findings cannot validate every topical peptide serum.
Category
Archive
116 stories · page 9 of 10
Science
Topical Exosomes for Skin Rejuvenation: Promising, but Not Standardized
A new 2026 scoping review finds encouraging signals for topical exosomes but major heterogeneity and standardization gaps.
Science
PDRN Is Everywhere. The Human Evidence Is Smaller Than the Hype
Seven randomized trials with 183 participants span different products, routes and indications; injectable findings cannot be transferred to retail topicals.
Skin
What 2026 Beauty Results Really Say: L’Oréal, Estée Lauder and Shiseido Compared
Three primary company disclosures point to very different kinds of beauty momentum in 2026. LCY compares the periods, metrics and category signals without turning unlike numbers into a false ranking.
Skin
‘Mask-Level’ Toner Claims: What Shiseido’s New Elixir Launch Can—and Cannot—Establish
Shiseido’s 21 August 2026 announcement of a new Elixir high-moisture lotion is a useful product-intelligence signal, but it is not independent proof of superior skin outcomes. LifeCareYou separates what the company has documented about the launch from what still needs finished-product, comparative and post-market evidence. The timely signal is the claim language: the release defines “mask-level” as moisturizing performance equivalent to an Elixir sheet mask, then separately states a...
Technology
Shade Matching Gets Scientific: What the Estée Lauder–Leeds Collaboration Can—and Cannot—Prove Yet
A new color-science collaboration targets better complexion matching. The research question is important—but the announcement is not yet a validation result.
Skin
Ingredient Intelligence: How LifeCareYou Reads Skincare Claims
Why an ingredient name alone cannot prove a skincare result, and how LCY compares concentration, formulation, finished-product evidence, safety and claim scope.
Trends
The LCY Edit: Trend Intelligence for Members and Subscribers
What subscribers receive from The LCY Edit, how sources and commercial relationships are labelled, and why unverified offers are never presented as member benefits.
Skin
K-Beauty’s U.S. Mainstream Moment: What Sephora × Olive Young Actually Signals
A primary-source read of the 2026 U.S. rollout—and why retail scale is a market signal, not proof that every product claim works.
Fashion
Fashion & Beauty Signals: How LifeCareYou Reads Seasonal Trends
A transparent method for separating a short-lived fashion or beauty moment from a repeated seasonal signal across markets, sources and time.
Technology
Beauty Tech Watch: How LCY Evaluates Devices and Digital Beauty
A practical LCY framework for separating useful beauty technology from premature claims by comparing intended use, evidence, safety, privacy and real-world limitations.
Science
Editorial Independence: Advertising, Sponsorships and Affiliate Links
LifeCareYou's editorial firewall: how advertising, sponsorship, branded content and affiliate links are labelled and kept separate from scientific judgment.